ArticleExperimental dermatology2022

Suppression of IL-12/IL-23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon-γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon-driven diseases.

Nanette L A Vincken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.